Role of Surgical Approach to Synchronous Colorectal Liver Metastases: A Retrospective Analysis
Open Access
- 1 May 2021
- journal article
- research article
- Published by Taylor & Francis in Cancer Management and Research
- Vol. ume 13, 3699-3711
Abstract
Purpose: This study is a retrospective analysis of exploring the efficiency of surgical management on patients with synchronous colorectal liver metastasis (SCLM). Patients and Methods: Nine hundred fifty-three consecutive patients with SCLM from Weifang People’s Hospital of Shandong Province between January 2006 and December 2015 were reviewed. The values of different factors were analyzed, such as different surgical indications of liver metastases, simultaneous or staged resection of primary colorectal cancer and liver metastases, and primary tumor resection (PTR) of asymptomatic patients with unresectable liver metastases. Results: Median survival time (47.3 months) and 5-year survival rate (31%) for patients with resected liver metastases were significantly superior to that of with nonoperative treatment (17.2 months, 4%, P< 0.001); enlarging the standard of liver metastases resection can improve the resection rates (31.0% vs 13.6%, P< 0.001); for patients with resectable liver metastases, the in-hospital cost for simultaneous resection group was lower than that in the staged resection group (36,698 vs 45,134 RMB, P< 0.001); for patients of the asymptomatic primary tumor with unresectable liver metastases, PTR was associated with improved median survival (18.0 vs 15.0 months, P=0.006). Conclusion: For patients with SCLM, liver resection is considered the best treatment; expanding indications of liver resection can improve the resection rates. Simultaneous resection of the primary tumor and liver metastases were indicated in patients with resectable SCLM; PTR was recommended for asymptomatic patients with unresectable hepatic metastases.Keywords
This publication has 36 references indexed in Scilit:
- Chinese guidelines for the diagnosis and comprehensive treatment of hepatic metastasis of colorectal cancerJournal of Cancer Research and Clinical Oncology, 2011
- Systemic chemotherapy and its implications for resection of colorectal liver metastasisSurgical Oncology, 2011
- Impact of Expanding Criteria for Resectability of Colorectal Metastases on Short- and Long-Term Outcomes After Hepatic ResectionAnnals of Surgery, 2011
- Improved Survival in Metastatic Colorectal Cancer Is Associated With Adoption of Hepatic Resection and Improved ChemotherapyJournal of Clinical Oncology, 2009
- Patients With Initially Unresectable Colorectal Liver Metastases: Is There a Possibility of Cure?Journal of Clinical Oncology, 2009
- Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from an expert panelAnnals of Oncology, 2009
- Management of hepatic metastasis from colorectal cancers: an updateJournal of Hepato-Biliary-Pancreatic Surgery, 2008
- Surgical Therapy for Colorectal Metastases to the LiverJournal of Gastrointestinal Surgery, 2007
- The role of synchronous procedures in the treatment of colorectal liver metastasesSurgical Oncology, 2007
- Colorectal cancer with synchronous liver metastasesBritish Journal of Surgery, 2007